Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,356 | 374 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $723.38 | 44 | $0 (2024) |
| PFIZER INC. | $677.29 | 67 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $488.42 | 44 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $405.52 | 26 | $0 (2022) |
| Novo Nordisk Inc | $367.63 | 23 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $323.99 | 21 | $0 (2021) |
| Amarin Pharma Inc. | $306.09 | 15 | $0 (2020) |
| VIVUS LLC | $278.42 | 17 | $0 (2021) |
| Horizon Therapeutics plc | $208.90 | 15 | $0 (2021) |
| Allergan Inc. | $196.70 | 17 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.01 | 10 | AstraZeneca Pharmaceuticals LP ($139.19) |
| 2023 | $281.74 | 15 | AstraZeneca Pharmaceuticals LP ($200.86) |
| 2022 | $369.95 | 21 | AstraZeneca Pharmaceuticals LP ($184.65) |
| 2021 | $445.43 | 26 | Janssen Pharmaceuticals, Inc ($65.00) |
| 2020 | $693.34 | 41 | Horizon Therapeutics plc ($105.64) |
| 2019 | $1,048 | 82 | PFIZER INC. ($262.66) |
| 2018 | $865.39 | 69 | Merck Sharp & Dohme Corporation ($220.17) |
| 2017 | $1,441 | 110 | Allergan Inc. ($185.46) |
All Payment Transactions
374 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Oncology | ||||||
| 09/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.88 | General |
| Category: Oncology | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.95 | General |
| Category: Respiratory | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Respiratory | ||||||
| 01/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 11/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Respiratory | ||||||
| 10/04/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Oncology | ||||||
| 09/30/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Respiratory | ||||||
| 07/05/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 06/14/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Respiratory | ||||||
| 05/15/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Oncology | ||||||
| 04/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Respiratory | ||||||
| 03/01/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 514 | 1,164 | $135,331 | $75,826 |
| 2022 | 7 | 547 | 1,209 | $134,816 | $76,399 |
| 2021 | 6 | 579 | 1,176 | $131,742 | $75,065 |
| 2020 | 8 | 705 | 1,545 | $145,685 | $67,145 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 610 | $64,050 | $35,068 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 258 | $39,990 | $21,226 | 53.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 157 | 157 | $29,830 | $19,236 | 64.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 24 | $1,008 | $201.59 | 20.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 27 | $189.00 | $88.66 | 46.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 88 | $264.00 | $6.21 | 2.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 603 | $63,315 | $33,289 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 164 | 164 | $31,160 | $20,584 | 66.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 229 | $35,495 | $19,881 | 56.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $3,025 | $2,336 | 77.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 19 | 29 | $1,218 | $228.62 | 18.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 21 | $147.00 | $68.79 | 46.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 152 | $456.00 | $10.96 | 2.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 536 | $56,280 | $29,079 | 51.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 261 | $40,455 | $23,194 | 57.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 174 | 174 | $33,060 | $22,387 | 67.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 32 | $1,344 | $316.39 | 23.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 21 | $147.00 | $69.60 | 47.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 152 | $456.00 | $19.03 | 4.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 177 | 353 | $54,715 | $22,845 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 191 | 465 | $48,825 | $20,543 | 42.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 174 | 174 | $33,060 | $19,512 | 59.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 20 | 20 | $4,000 | $3,240 | 81.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 49 | 66 | $2,772 | $556.93 | 20.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 27 | 36 | $900.00 | $324.97 | 36.1% |
About Dr. Anthony Lanier, DO
Dr. Anthony Lanier, DO is a Internal Medicine healthcare provider based in Niles, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1184606766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Lanier, DO has received a total of $5,356 in payments from pharmaceutical and medical device companies, with $212.01 received in 2024. These payments were reported across 374 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,356).
As a Medicare-enrolled provider, Lanier has provided services to 2,345 Medicare beneficiaries, totaling 5,094 services with total Medicare billing of $294,435. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Niles, OH
- Active Since 11/18/2005
- Last Updated 07/15/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1184606766
Products in Payments
- JANUVIA (Drug) $431.00
- XARELTO (Drug) $376.02
- CHANTIX (Drug) $336.77
- FARXIGA (Drug) $335.14
- Vascepa (Drug) $306.09
- Saxenda (Drug) $295.51
- BREZTRI (Drug) $268.35
- QSYMIA (Drug) $260.80
- JARDIANCE (Drug) $213.48
- ELIQUIS (Drug) $181.18
- TRADJENTA (Drug) $172.89
- VRAYLAR (Drug) $159.80
- PENNSAID (Drug) $125.41
- NEXLETOL (Drug) $123.11
- Cologuard Collection Kit (Device) $119.15
- AIRSUPRA (Drug) $84.24
- Repatha (Biological) $81.16
- BREO (Drug) $77.23
- VIMOVO (Drug) $76.16
- Prolia (Biological) $70.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Niles
Dr. Ramona Sheth, M.d.,, M.D.,
Internal Medicine — Payments: $21,982
Dr. Sanjay Sheth, M.d, M.D
Internal Medicine — Payments: $17,755
Basem Doss, Md, MD
Internal Medicine — Payments: $12,848
Dr. Peter Sargon, M.d, M.D
Internal Medicine — Payments: $7,824
Dr. Bahaa Awadalla, M.d, M.D
Internal Medicine — Payments: $7,824
Dr. Heba Mikhail, M.d, M.D
Internal Medicine — Payments: $7,463